Elsevier is Meeting Today's Medical Students' Needs With Online, Mobile and Print Tools
PHILADEPHIA, February 22, 2010 /PRNewswire-FirstCall/ --
- Company Celebrates Medical Education Innovation at AMSA's 60th Anniversary Convention
Elsevier, the leading publisher of scientific, technical and medical information, today announced it is celebrating medical education innovation at the American Medical Student Association's (AMSA) 60th Annual Convention (http://www.amsa.org/AMSA/Homepage/Events/Convention.aspx), March 11-14, 2010, at the Disneyland Hotel in Anaheim, California.
"Elsevier is committed to supporting the 'passion, professionalism (and) pride' of up-and-coming physicians through a full range of online, print and mobile resources, including USMLE Consult, Student Consult and our new 3-D virtual reality product InteractElsevier," says Randy Charles, Managing Director for Elsevier Health Sciences Global Clinical Reference Group. "No matter what the preferences of today's medical students, Elsevier has the resources to meet their learning styles, study schedules and budgets."
Among the resources that Elsevier will showcase at AMSA are: - Student Consult (http://www.studentconsult.com/), which provides full-text, online access to top medical education titles such as the new edition of Netter's Atlas of Human Anatomy, along with additional study tools like image banks, questions, animations, and a virtual microscope - USMLE Consult (http://www.usmleconsult.com/), which offers USMLE test preparation guidance, simulations, review plans and remediation - InteractElsevier (http://www.interactelsevier.com/), which explores human anatomy and virtual dissection through 3-D virtual reality technology - Mobile applications (http://www.us.elsevierhealth.com/app) such as Netter's Anatomy Flash Cards
The first 1,000 AMSA student attendees who visit the Elsevier booth (#18-19) will receive a complimentary three-month subscription to USMLE Consult (http://www.usmleconsult.com/usmle-step-one/usmle-step-one.cfm) Step 1 Question Bank Review Plan, with content from respected Elsevier resources such as Gray's Anatomy and officially reviewed and approved by Edward Goljan, M.D., Professor and Chairman of Pathology, Oklahoma State University, College of Osteopathic Medicine.
Dr. Goljan, who calls Elsevier "the undisputed leader in medical education" and a "premier health sciences information source," will meet attendees at the Elsevier booth and sign copies of his popular book, Rapid Review Pathology (http://www.us.elsevierhealth.com/product.jsp?lid=1&iid=0&sid=958&isbn= 9780323068628). He will also headline an Elsevier-sponsored session, USMLE - Prepping with Dr. Goljan and the Rapid Review Series, on Friday, March 12, from 2-2:50 p.m.
(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell (http://www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and Nursing Consult (http://www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier (http://www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Contact: Tom Reller Vice President, Global Corporate Relations +1-212-462-1912 [email protected]
SOURCE Elsevier
Share this article